Antemortem Prediction of Braak Stage

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2015-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/NEN.0000000000000251PMID 26469248PMCID PMC4610255
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological changes in aging brain.

  2015cited by this paper
• Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

  2015cited by this paper
• Usefulness of Biomarkers in the Diagnosis and Prognosis of Early-Onset Cognitive Impairment

  2014cited by this paper
• PART and SNAP

  2014cited by this paper
• Treatment of vascular risk factors in patients with a diagnosis of Alzheimer’s disease: a systematic review

  2014cited by this paper
• Primary age-related tauopathy (PART): a common pathology associated with human aging

  2014cited by this paper
• Fluid biomarkers in Alzheimer’s disease – current concepts

  2013cited by this paper
• Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing

  2013cited by this paper
• Excess mortality during hospital stays among patients with recorded diabetes compared with those without diabetes

  2013cited by this paper
• Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series

  2013cited by this paper
• Relation of neuropathology with cognitive decline among older persons without dementia

  2013cited by this paper
• Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research

  2013cited by this paper
• The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease

  2013cited by this paper
• Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.

  2013cited by this paper
• Neuropathologic Correlates of Cognition in a Population-Based Sample

  2013cited by this paper
• Neuropsychology of Alzheimer's disease.

  2012cited by this paper
• The neurobiology of Alzheimer disease defined by neuroimaging.

  2012cited by this paper
• National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

  2012cited by this paper
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

  2012cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease

  2011cited by this paper
• Alzheimer Disease Pathology in Subjects Without Dementia in 2 Studies of Aging: The Nun Study and the Adult Changes in Thought Study

  2011cited by this paper
• Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease.

  2011influential reference
• APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging

  2010cited by this paper
• Neuropathology of Alzheimer's disease.

  2010cited by this paper
• Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes.

  2010cited by this paper
• Dementia risk prediction: are we there yet?

  2010cited by this paper
• Combining MRI and MRS to Distinguish Between Alzheimer's Disease and Healthy Controls

  2010cited by this paper
• Diabetes, Alzheimer disease, and vascular dementia

  2010cited by this paper
• Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

  2009cited by this paper
• Midlife and late-life obesity and the risk of dementia: cardiovascular health study.

  2009cited by this paper
• Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease

  2009cited by this paper
• Mid- and Late-Life Diabetes in Relation to the Risk of Dementia

  2009cited by this paper
• Prognosis and prognostic research: Developing a prognostic model

  2009cited by this paper
• Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study

  2009cited by this paper
• Neuropathological Correlates of Dementia in Over-80-Year-Old Brain Donors from the Population-Based Cambridge City over-75s Cohort (CC75C) Study

  2009cited by this paper
• A survey of ABCA1 sequence variation confirms association with dementia

  2009cited by this paper
• Age and apoE associations with complex pathologic features in Alzheimer's disease.

  2008cited by this paper
• Neuropsychology of Alzheimer's disease.

  2008cited by this paper
• O1‐05–08: Mid‐ and late‐life diabetes in relation to the risk of dementia: A population‐based twin study

  2008cited by this paper
• AD brain pathology: vascular origins? Results from the HAAS autopsy study.

  2008cited by this paper
• The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer’s Disease

  2007cited by this paper
• Cardiovascular risk factors for Alzheimer's disease.

  2007cited by this paper
• Pathological correlates of dementia in a longitudinal, population‐based sample of aging

  2007influential reference
• Body mass index in older persons is associated with Alzheimer disease pathology

  2006cited by this paper
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry

  2006influential reference
• Brain Aging in Very Old Men With Type 2 Diabetes

  2006influential reference
• Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle‐only dementia): The Hisayama study

  2006cited by this paper
• SPECIAL SERIES: MISSING DATA Review: A gentle introduction to imputation of missing values

  2006cited by this paper
• Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study.

  2006influential reference
• Cognitive status correlates with neuropathologic stage in Parkinson disease

  2005cited by this paper
• Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions

  2005cited by this paper
• Trends in cardiovascular complications of diabetes.

  2005influential reference
• Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study.

  2005cited by this paper
• Trends in cardiovascular complications of diabetes.

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Neuropathology of Alzheimer’s Disease

  2004cited by this paper
• Processing Speed and Longitudinal Trajectories of Change for Cognitive Abilities: The Swedish Adoption/Twin Study of Aging

  2004cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Co-morbidity associated with dementia

  2002cited by this paper
• Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study

  2002cited by this paper
• Gender and health: a study of older unlike-sex twins.

  2002cited by this paper
• The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies

  2002cited by this paper
• Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  2002cited by this paper
• Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

  2000cited by this paper
• Severity of Cardiovascular Disease, Apolipoprotein E Genotype, and Brain Pathology in Aging and Dementia

  2000cited by this paper
• Accurate Prediction of Histologically Confirmed Alzheimer's Disease and the Differential Diagnosis of Dementia: The Use of NINCDS-ADRDA and DSM-III-R Criteria, SPECT, X-Ray CT, and Apo E4 in Medial Temporal Lobe Dementias

  1998cited by this paper
• Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects

  1997cited by this paper
• Substantial genetic influence on cognitive abilities in twins 80 or more years old.

  1997cited by this paper
• Accurate Prediction of Histologically Confirmed Alzheimer's Disease and the Differential Diagnosis of Dementia: The Use of NINCDS-ADRDA and DSM-III-R Criteria, SPECT, X-Ray CT, and Apo E4 in Medial Temporal Lobe Dementias

  1997cited by this paper
• Cognitive predictors of incident Alzheimer's disease: a prospective longitudinal study.

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging.

  1996cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery

  1994cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease

  1989cited by this paper
• Are Alzheimer Patients Healthier?

  1988cited by this paper
• Why are Alzheimer patients thin?

  1988cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Associations between Structural Neuroimaging Markers and Neuropathology of Alzheimer's Disease.

  2026cites this paper
• Brain DNA Methylation Age, Lifestyle Factors and Dementia in the Swedish Twin Registry

  2025cites this paper
• Calcineurin inhibition prevents synaptic plasticity deficit induced by brain-derived tau oligomers

  2024cites this paper
• Corpora amylacea negatively correlate with hippocampal tau pathology in Alzheimer’s disease

  2024cites this paper
• Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer's disease neuropathology.

  2021cites this paper
• Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease.

  2021cites this paper
• Telephone Interview for Cognitive Status Scores Associate with Cognitive Impairment and Alzheimer’s Disease Pathology at Death

  2021cites this paper
• Mid to late‐life scores of depression in the cognitively healthy are associated with cognitive status and Alzheimer's disease pathology at death

  2020cites this paper
• Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer’s Disease

  2020influential citation
• The Contribution of Vascular Pathology Toward Cognitive Impairment in Older Individuals with Intermediate Braak Stage Tau Pathology

  2020cites this paper
• In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer’s disease

  2019cites this paper
• Scores Obtained from a Simple Cognitive Test of Visuospatial Episodic Memory Performed Decades before Death Are Associated with the Ultimate Presence of Alzheimer Disease Pathology

  2018cites this paper
• Population‐based analysis of pathological correlates of dementia in the oldest old

  2017cites this paper
• Few serum proteins mediate APOE’s association with dementia

  2017cites this paper
• Pathological correlates of cognitive impairment and dementia in a longitudinally assessed cohort of elderly people

  2016cites this paper